PubMed

Enzyme therapy in type 1 Gaucher disease: comparative efficacy of mannose-terminated glucocerebrosidase from natural and recombinant sources.

Grabowski GA, Barton NW, Pastores G, Dambrosia JM, Banerjee TK, McKee MA, Parker C, Schiffmann R, Hill SC, Brady RO.

Ann Intern Med. 1995 Jan 1;122(1):33-9.PMID: 7985893 [PubMed - indexed for MEDLINE]Related articlesFree article

A randomized trial comparing the efficacy and safety of imiglucerase (Cerezyme) infusions every 4 weeks versus every 2 weeks in the maintenance therapy of adult patients with Gaucher disease type 1.

Kishnani PS, DiRocco M, Kaplan P, Mehta A, Pastores GM, Smith SE, Puga AC, Lemay RM, Weinreb NJ.

Mol Genet Metab. 2009 Apr;96(4):164-70. Epub 2009 Feb 4.PMID: 19195916 [PubMed - indexed for MEDLINE]Related articles

[Alglucerase treatment of type I Gaucher's disease. Preliminary results in Spain. Spanish Group on Gaucher's Disease]

Pérez-Calvo JI, Giraldo P, Giralt M.

Sangre (Barc). 1997 Jun;42(3):189-94. Spanish. PMID: 9381260 [PubMed - indexed for MEDLINE]Related articles

Outcome of enzyme replacement therapy in patients with Gaucher disease type I. The Romanian experience.

Grigorescu Sido P, Drugan C, Cret V, Al-Kzouz C, Denes C, Coldea C, Zimmermann A.

J Inherit Metab Dis. 2007 Oct;30(5):783-9. Epub 2007 Aug 20.PMID: 17703370 [PubMed - indexed for MEDLINE]Related articles

Enzyme therapy in Gaucher disease type 1: dosage efficacy and adverse effects in 33 patients treated for 6 to 24 months.

Pastores GM, Sibille AR, Grabowski GA.

Blood. 1993 Jul 15;82(2):408-16.PMID: 8392397 [PubMed - indexed for MEDLINE]Related articlesFree article

Imiglucerase low-dose therapy for paediatric Gaucher disease--a long-term cohort study.

Heitner R, Arndt S, Levin JB.

S Afr Med J. 2004 Aug;94(8):647-51.PMID: 15352589 [PubMed - indexed for MEDLINE]Related articles

Comparative efficacy of dose regimens in enzyme replacement therapy of type I Gaucher disease.

Altarescu G, Schiffmann R, Parker CC, Moore DF, Kreps C, Brady RO, Barton NW.

Blood Cells Mol Dis. 2000 Aug;26(4):285-90.PMID: 11042029 [PubMed - indexed for MEDLINE]Related articles

Enzyme replacement therapy for Gaucher disease.

Beutler E, Kay A, Saven A, Garver P, Thurston D, Dawson A, Rosenbloom B.

Blood. 1991 Sep 1;78(5):1183-9.PMID: 1878585 [PubMed - indexed for MEDLINE]Related articlesFree article

Management of neutralizing antibody to Ceredase in a patient with type 3 Gaucher disease.

Brady RO, Murray GJ, Oliver KL, Leitman SF, Sneller MC, Fleisher TA, Barton NW.

Pediatrics. 1997 Dec;100(6):E11.PMID: 9382912 [PubMed - indexed for MEDLINE]Related articles

Decreased bone density in splenectomized Gaucher patients receiving enzyme replacement therapy.

Schiffmann R, Mankin H, Dambrosia JM, Xavier RJ, Kreps C, Hill SC, Barton NW, Rosenthal DI.

Blood Cells Mol Dis. 2002 Mar-Apr;28(2):288-96.PMID: 12064924 [PubMed - indexed for MEDLINE]Related articles

First long-term results of imiglucerase therapy of type 1 Gaucher disease.

Niederau C, vom Dahl S, Häussinger D.

Eur J Med Res. 1998 Feb 21;3(1-2):25-30.PMID: 9512964 [PubMed - indexed for MEDLINE]Related articles

Gaucher disease, enzyme replacement therapy, and the Patient Assistance Program.

Goldwater RS.

J Intraven Nurs. 1996 Mar-Apr;19(2):83-8. Erratum in: J Intraven Nurs 1996 May-Jun;19(3):158. PMID: 8852168 [PubMed - indexed for MEDLINE]Related articles

Imiglucerase treatment in Gaucher's disease.

Shah U, Nadeem N, Husen Y, Fadoo Z.

J Ayub Med Coll Abbottabad. 2007 Apr-Jun;19(2):56-9.PMID: 18183722 [PubMed - indexed for MEDLINE]Related articles

Replacement therapy for inherited enzyme deficiency--macrophage-targeted glucocerebrosidase for Gaucher's disease.

Barton NW, Brady RO, Dambrosia JM, Di Bisceglie AM, Doppelt SH, Hill SC, Mankin HJ, Murray GJ, Parker RI, Argoff CE, et al.

N Engl J Med. 1991 May 23;324(21):1464-70.PMID: 2023606 [PubMed - indexed for MEDLINE]Related articles

Cessation of enzyme replacement therapy in Gaucher disease.

Grinzaid KA, Geller E, Hanna SL, Elsas LJ 2nd.

Genet Med. 2002 Nov-Dec;4(6):427-33.PMID: 12509713 [PubMed - indexed for MEDLINE]Related articles

Differential effects of enzyme supplementation therapy on manifestations of type 1 Gaucher disease.

Hollak CE, Corssmit EP, Aerts JM, Endert E, Sauerwein HP, Romijn JA, van Oers MH.

Am J Med. 1997 Sep;103(3):185-91.PMID: 9316550 [PubMed - indexed for MEDLINE]Related articles

Dose-response relationships for enzyme replacement therapy with imiglucerase/alglucerase in patients with Gaucher disease type 1.

Grabowski GA, Kacena K, Cole JA, Hollak CE, Zhang L, Yee J, Mistry PK, Zimran A, Charrow J, vom Dahl S.

Genet Med. 2009 Feb;11(2):92-100.PMID: 19265748 [PubMed - indexed for MEDLINE]Related articles

Enzyme replacement therapy for Gaucher disease in Australia.

Goldblatt J, Szer J, Fletcher JM, McGill J, Rowell JA, Wilson M.

Intern Med J. 2005 Mar;35(3):156-61.PMID: 15737135 [PubMed - indexed for MEDLINE]Related articles

[Enzyme replacement therapy in Gaucher disease: monitoring visceral and bone changes with MRI]

Tóth J, Szücs FZ, Benkö K, Maródi L.

Orv Hetil. 2003 Apr 20;144(16):749-55. Hungarian. PMID: 12778625 [PubMed - indexed for MEDLINE]Related articles

[French results of enzyme replacement therapy in Gaucher's disease]

Schaison G, Caubel I, Belmatoug N, Billette de Villemeur T, Saudubray JM.

Bull Acad Natl Med. 2002;186(5):851-61; discussion 861-3. French. PMID: 12412377 [PubMed - indexed for MEDLINE]Related articles